Conference Speakers

Conference Speakers and Panelists | 2025

Devang Bhuva

Senior Vice President, Corporate Development

Gilead Sciences

Kate Bingham, DBE

Managing Partner

SV Health Investors

Sarah Boyce

President & CEO

Avidity Biosciences

Jeremy Caldwell, Ph.D.

Partner

Red Tree Venture Capital

Mira Chaurushiya, Ph.D.

Managing Director

Westlake Village BioPartners

Shelley Chu, M.D., Ph.D.

Partner

Lightspeed Ventures

Ben Cravatt, Ph.D.

Professor & Gilula Chair, Chemical Biology

The Scripps Research Institute

Thomas Daniel, M.D.

Director, Scripps Research; Chair & Founder

Life Science Cares San Diego

Shawna Frazier

Director, West Coast Ventures

AbbVie

Jennifer Giottonini Cayer

Chief Business Officer, Pulmocide; Board Member, Biocom California; Board Member

UCSD Moore’s Cancer Center

Richard Glynne, Ph.D.

Venture Partner; President & CSO, Inception Therapeutics Discovery Engine

Versant Ventures

Corey Goodman, Ph.D.

Managing Partner

venBio Partners

Luba Greenwood

Managing Partner, Binney Street Capital Venture Fund

Dana-Farber Cancer Institute

Jason Hafler

Managing Director

Sanofi Ventures

Kent Hawryluk

President & CEO

MBX Biosciences

Richard Heyman, Ph.D.

Venture Partner

ARCH Ventures

Tony Ho

Chief Scientific Officer & Senior Science Partner

Pivotal Life Sciences

John Hood, Ph.D.

Founder, CEO & Executive Chairman

Endeavor BioMedicines

Rachna Khosla

Senior Vice President, Business Development

Amgen

Nina Kjellson

General Partner

Canaan Partners

John Lepore, M.D.

CEO, ProFound Therapeutics; CEO-Partner

Flagship Pioneering

Jay Lichter, Ph.D.

Managing Director

Avalon Ventures

Kevin Lind

President & CEO

Longboard Pharmaceuticals

Tim Luker, Ph.D.

Vice President, Venture Science, West Coast USA Head, Corp BD

Eli Lilly and Company

Bill Martin, Ph.D.

Global Therapeutic Area Head, Neuroscience

Johnson & Johnson Innovative Medicine

Shlomo Melmed, M.D.

Dean

Cedars-Sinai Medical Center

Detlev Mennerich, Ph.D.

Corporate SVP, Global Head of Business Development & Licensing

Boehringer Ingelheim

Thomas Miller

Co-Founder & CEO

Iambic Therapeutics

Daria Mochly-Rosen, Ph.D.

Founder, SPARK at Stanford & The George D. Smith Professor of Translational Medicine

Stanford University School of Medicine

Brett Monia, Ph.D.

CEO

Ionis Pharmaceuticals

Mitchell Mutz, Ph.D.

Entrepreneur Partner

Vivo Capital

Amir Nashat, Ph.D.

Board Chair, Paratus Sciences; Managing Partner

Polaris Partners

Carolyn Ng, Ph.D.

Partner & Managing Director

TPG Life Sciences Innovations

Carole Nuechterlein

Head

Roche Venture Fund

Daniel O’Connell, M.D., Ph.D.

Partner

Novo Ventures

Deborah Palestrant, Ph.D.

Partner & Executive Chair, 4:59 Initiative

5AM Ventures

Mark Paris, Ph.D.

Executive Director, Oncology Search and Evaluation

Daiichi Sankyo

Sunil Patel

Head of Corporate Development and Business Development & Licensing

Merck

Steven Paul, M.D.

Board Chair, FNIH; Venture Partner

Third Rock Ventures

Jeremy Quirk

VP BD&L Commercial Portfolio

GSK

Mary Rozenman, Ph.D.

CFO & CBO

insitro

Camille Samuels

Partner

Venrock

James Schaeffer, Ph.D.

Vice President, Business Strategy

PhenoTarget

Ken Song, M.D.

Chairman, President & CEO

Candid Therapeutics

Avi Spier, Ph.D.

Executive Director, Search & Evaluation

Novartis

Jay Stamatis

Vice President, Head of Business Development and Acquisitions

AbbVie

Tari Suprapto, Ph.D.

Director, Search & Evaluation (West)

Novo Nordisk

Marc Tessier-Lavigne, Ph.D.

CEO

Xaira Therapeutics

Matt Tremblay, Ph.D.

Chief Executive Officer

Blackbird Laboratories

Court Turner

Partner

LYZZ Capital

D.A. Wallach

General Partner & Co-Founder

Time BioVentures

Bradley Wolff

Senior Managing Director

Evercore

Fan Zhang, Ph.D.

Oncology Search and Evaluation Lead, Worldwide Business Development

Pfizer